164 related articles for article (PubMed ID: 38811865)
21. Oral complications at 6 months after radiation therapy for head and neck cancer.
Lalla RV; Treister N; Sollecito T; Schmidt B; Patton LL; Mohammadi K; Hodges JS; Brennan MT;
Oral Dis; 2017 Nov; 23(8):1134-1143. PubMed ID: 28675770
[TBL] [Abstract][Full Text] [Related]
22. The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.
Liu M; An R; Wu Z; Dai L; Zeng Q; Chen W
Ear Nose Throat J; 2024 Feb; ():1455613241228211. PubMed ID: 38334289
[TBL] [Abstract][Full Text] [Related]
23. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
24. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Acute Toxicities, Overall Treatment Time and Quality of Life in Head and Neck Cancer Patients Treated with IMRT and Helical Tomotherapy.
R YB; Swamy K; Swaroopa C; Maiya V
Gulf J Oncolog; 2024 May; 1(45):7-14. PubMed ID: 38774928
[TBL] [Abstract][Full Text] [Related]
26. Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment.
Nagarajan K
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e273-7. PubMed ID: 25662542
[TBL] [Abstract][Full Text] [Related]
27. Effect of Honey-Lemon Spray Versus Benzydamine Hydrochloride Spray on Radiation-Induced Acute Oral Mucositis in Head and Neck Cancer Patients: A Pilot, Randomized, Double-Blind, Active-Controlled Clinical Trial.
Ameri A; Poshtmahi S; Heydarirad G; Cramer H; Choopani R; Hajimehdipoor H; Azghandi S; Pasalar M
J Altern Complement Med; 2021 Mar; 27(3):255-262. PubMed ID: 33512251
[No Abstract] [Full Text] [Related]
28. Evaluation of oral prophylaxis during and after intensity-modulated radiotherapy due to head and neck cancer--a retrospective study.
Bichsel D; Lanfranchi M; Attin T; Grätz KW; Stadlinger B
Clin Oral Investig; 2016 May; 20(4):721-6. PubMed ID: 26250794
[TBL] [Abstract][Full Text] [Related]
29. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
[TBL] [Abstract][Full Text] [Related]
30. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
31. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
[TBL] [Abstract][Full Text] [Related]
32. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
33. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
[TBL] [Abstract][Full Text] [Related]
34. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G; Gupta G; Malviya A; Saroj D
J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
36. Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study.
Kiyomi A; Yoshida K; Arai C; Usuki R; Yamazaki K; Hoshino N; Kurokawa A; Imai S; Suzuki N; Toyama A; Sugiura M
PLoS One; 2022; 17(4):e0267092. PubMed ID: 35476641
[TBL] [Abstract][Full Text] [Related]
37. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
38. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of optimizing intensity-modulated radiation therapy plans based on measured mucosal dose adjacent to dental fillings and toxicity outcomes.
Seol SW; Aggarwal S; von Eyben R; Wang Z; Chan C; Say C; Xing L; Hara W; Yang Y; Le QT
J Appl Clin Med Phys; 2018 Sep; 19(5):444-452. PubMed ID: 29984915
[TBL] [Abstract][Full Text] [Related]
40. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
